Nikhil Chopra

JB Pharma publishes its second ESG report for FY 2022-23

Read more

JB Pharma: Betting big on India

Read more

JB Chemicals closely watching for acquisition opportunities

Read more

My role is to act like a catalyst

Read more

JB Chemicals & Pharmaceuticals appoints Nikhil Chopra as CEO

Read more

Cipla launches Cipremi, likely to price it Rs 4,000 per vial

Read more

Cipla acquires four nutraceutical brands of Wanbury

Read more